Das Sanskrita, Nam Hyoryung, Jang Jinah
Department of Convergence IT Engineering, POSTECH, 77 Cheongam-ro, Namgu, Pohang, Kyungbuk 37673, Republic of Korea.
APL Bioeng. 2021 Jul 27;5(3):031508. doi: 10.1063/5.0030353. eCollection 2021 Sep.
Stem cell-laden three-dimensional (3D) bioprinted cardiac patches offer an alternative and promising therapeutic and regenerative approach for ischemic cardiomyopathy by reversing scar formation and promoting myocardial regeneration. Numerous studies have reported using either multipotent or pluripotent stem cells or their combination for 3D bioprinting of a cardiac patch with the sole aim of restoring cardiac function by faithfully rejuvenating the cardiomyocytes and associated vasculatures that are lost to myocardial infarction. While many studies have demonstrated success in mimicking cardiomyocytes' behavior, improving cardiac function and providing new hope for regenerating heart post-myocardial infarction, some others have reported contradicting data in apparent ways. Nonetheless, all investigators in the field are speed racing toward determining a potential strategy to effectively treat losses due to myocardial infarction. This review discusses various types of candidate stem cells that possess cardiac regenerative potential, elucidating their applications and limitations. We also brief the challenges of and an update on the implementation of the state-of-the-art 3D bioprinting approach to fabricate cardiac patches and highlight different strategies to implement vascularization and augment cardiac functional properties with respect to electrophysiological similarities to native tissue.
负载干细胞的三维(3D)生物打印心脏补片为缺血性心肌病提供了一种替代性的、有前景的治疗和再生方法,可通过逆转瘢痕形成和促进心肌再生来实现。众多研究报告称,使用多能或多潜能干细胞或其组合进行心脏补片的3D生物打印,其唯一目的是通过忠实地使因心肌梗死而丧失的心肌细胞和相关脉管系统恢复活力,从而恢复心脏功能。虽然许多研究已证明在模拟心肌细胞行为、改善心脏功能以及为心肌梗死后心脏再生提供新希望方面取得了成功,但也有其他一些研究报告了明显相互矛盾的数据。尽管如此,该领域的所有研究人员都在竞相确定一种有效治疗心肌梗死所致损伤的潜在策略。本综述讨论了具有心脏再生潜力的各类候选干细胞,阐明了它们的应用和局限性。我们还简要介绍了采用最先进的3D生物打印方法制造心脏补片所面临的挑战和最新进展,并强调了在实现血管化以及增强与天然组织电生理相似性的心脏功能特性方面的不同策略。